EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System

Jiasong Chang iD, Xiulong Yang, Tong Zhang iD, Hao Sun, Hongying Cheng, Zhangrong Jia iD, Yiying Li, Sanyuan Ma, Teng Sun, Jimin Cao

Molecules · 2025

DOI: 10.3390/molecules30081811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jiasong Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cellular Physiology, Shanxi Medical University, Ministry of Education, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, High-Throughput Screening Assays. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Program of Shanxi Province, National Natural Science Foundation of China, NSFC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome editing is a promising therapeutic strategy for genetic disorders by modifying the genome precisely, especially the CRISPR/Cas9 system. However, a major limitation of CRISPR/Cas9 in gene therapy is the biosafety issues caused by off-target effects. Compounds that can modulate the genome editing efficiency of the CRISPR/Cas9 system, especially those reducing the off-target effects, are potentially useful pharmacological tools for improving the effectiveness and safety of genome editing. Here, we performed high-throughput screening in HEK 293FT cells to discover compounds that decrease or increase the genome editing efficiency of the CRISPR/Cas9 system from 9930 compounds. After two rounds of screening, we identified that CP-724714, a ErbB2 (HER2) tyrosine kinase inhibitor, decreased the CRISPR/Cas9 efficiency and reduced the off-target effects by suppressing the efficiency of CRISPR/Cas9, and was thus named a CRISPR decelerator (or inhibitor), while Clofarabine, a DNA synthesis inhibitor, increased the efficiency of CRISPR/Cas9, and was named a CRISPR accelerator. We further identified four compounds (Tranilast, Cerulenin, Rosolic acid and Resveratrol) that affected the efficiency of single-strand annealing (SSA) repair. Among them, Tranilast, Cerulenin and Rosolic acid are potential SSA decelerators, while Resveratrol is a potential SSA accelerator. These identified compounds may be useful in optimizing mammalian genetic manipulation techniques.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsHigh-Throughput Screening AssaysHumansHEK293 Cells

Stichwörter der Autor:innen

CRISPR/Cas9compoundhigh-throughput screeningoff-target effectsingle-strand annealing

Autor:innen und Institutionen

  • Key Laboratory of Cellular Physiology, Shanxi Medical University, Ministry of Education, Taiyuan 030001, China.
  • Department of Physiology, Shanxi Medical University, Taiyuan 030001, China.
  • Biological Science Research Center, Southwest University, Chongqing 400715, China.
  • Department of Preschool Education, Lvliang Teachers College, Lvliang 033001, China.

ORCID-Profile: Jiasong Chang, Tong Zhang, Zhangrong Jia

Förderung

  • Applied Basic Research Program of Shanxi Province
  • National Natural Science Foundation of China
  • NSFC

Zitieren

APA

Chang, J., Yang, X., Zhang, T., Sun, H., Cheng, H., Jia, Z., Li, Y., Ma, S., Sun, T., & Cao, J. (2025). High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System. Molecules. https://doi.org/10.3390/molecules30081811

Vancouver

Chang J, Yang X, Zhang T, Sun H, Cheng H, Jia Z, et al. High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System. Molecules. 2025. doi:10.3390/molecules30081811

BibTeX
@article{Chang2025,
  author = {Chang, Jiasong and Yang, Xiulong and Zhang, Tong and Sun, Hao and Cheng, Hongying and Jia, Zhangrong and Li, Yiying and Ma, Sanyuan and Sun, Teng and Cao, Jimin},
  title = {High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30081811}
}
Kostenlos starten →